NKMAX Attends Global Conference with US Subsidiary
NKMAX announced on the 22nd that its subsidiary NKGen Biotech will participate in the Cantor Fitzgerald Global Healthcare Conference 2023 held in the United States.
The conference gathers experts from various industries such as life sciences, pharmaceuticals, and venture capital. These experts are expected to provide various ideas through company presentations, meetings, and discussions. This year, the event will be held in New York from the 26th to the 28th of this month.
NKGen Biotech will participate in the conference on the 27th to explain the overall technology of its NK cell therapy (SNK) and present its vision and growth strategy.
An NKMAX representative stated, “As our subsidiary NKGen Biotech is approaching its listing, we are participating in various global conferences to establish a foundation for becoming a global company,” adding, “After the listing, we plan to continue growth by expanding our clinical pipeline.”
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Meanwhile, NKGen Biotech is expected to complete its listing on the US Nasdaq within this month.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
